Evidence supporting the use of: Iron
For the health condition: Fibroids (uterine)

Links: Go back one page, Tool main page, Ingredients list, Health conditions list, Body systems list

Synopsis

Source of validity: Scientific
Rating (out of 5): 5

Iron is commonly used in the management of uterine fibroids, but not because it treats or shrinks the fibroids themselves. Instead, its use is scientifically justified as a supportive therapy to address iron-deficiency anemia, a frequent complication in women with uterine fibroids. Fibroids can cause heavy menstrual bleeding (menorrhagia), which often leads to significant blood loss and subsequent depletion of the body's iron stores. This can result in symptoms such as fatigue, weakness, and shortness of breath associated with anemia.

Multiple clinical guidelines and scientific studies support the use of iron supplementation in women with fibroid-related heavy menstrual bleeding. Oral or sometimes intravenous iron is prescribed to restore normal hemoglobin and hematocrit levels, thereby improving quality of life and reducing anemia-related symptoms. The goal of iron therapy in these cases is not to treat the fibroids directly, but to manage the anemia caused by fibroid-associated bleeding. The evidence for iron’s use in this context is robust, as correcting iron deficiency is a standard medical practice with clear clinical endpoints and measurable benefits.

In summary, while iron does not have an effect on the fibroids per se, its use as a supportive therapy for anemia in women with fibroids is well-established and strongly supported by scientific evidence.

More about iron
More about Fibroids (uterine)